Production (Stage)
CareRx Corporation
CRRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.52M | 267.68M | 268.79M | 270.63M | 273.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 263.52M | 267.68M | 268.79M | 270.63M | 273.75M |
| Cost of Revenue | 185.72M | 188.81M | 190.57M | 191.97M | 195.46M |
| Gross Profit | 77.81M | 78.87M | 78.22M | 78.66M | 78.29M |
| SG&A Expenses | 72.66M | 73.89M | 72.00M | 72.79M | 72.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 258.38M | 262.70M | 262.57M | 264.76M | 268.03M |
| Operating Income | 5.14M | 4.98M | 6.22M | 5.86M | 5.72M |
| Income Before Tax | -2.69M | -3.24M | -4.50M | -5.31M | -5.89M |
| Income Tax Expenses | 22.90K | 22.90K | -127.20K | -127.20K | -3.12M |
| Earnings from Continuing Operations | -2.72 | -3.26 | -4.37 | -5.18 | -2.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.72M | -3.26M | -4.37M | -5.18M | -2.77M |
| EBIT | 5.14M | 4.98M | 6.22M | 5.86M | 5.72M |
| EBITDA | 16.11M | 16.88M | 18.26M | 16.72M | 17.69M |
| EPS Basic | -0.05 | -0.05 | -0.07 | -0.09 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.01 | -0.03 | -0.04 |
| EPS Diluted | -0.05 | -0.05 | -0.08 | -0.09 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.01 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 243.88M | 241.02M | 238.73M | 236.38M | 233.91M |
| Average Diluted Shares Outstanding | 246.34M | 241.02M | 238.73M | 236.38M | 239.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |